Compare iShares iBoxx $ High Yield Corporate Bond ETF (HYG) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ High Yield Corporate Bond ETF vs McKesson Corporation — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.65, while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation pays a 0.39% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none, and McKesson Corporation is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| HYG | MCK | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $81.32 | $995.69 |
52-Week Low | $78.72 | $659.01 |
Market Cap | — | $97.35B |
Enterprise Value | — | $101.98B |
Dividend Yield | — | 0.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HYG trades at $79.68 with minimal daily movement, showing a slight gain of 0.04%. Technical indicators are bearish overall, with moving averages signaling sell pressure and oscillators neutral. Recent dividends include H1-26 payments of $0.41 and $0.42, with another $0.37 scheduled for H2-26. Bond ETF inflows are surging, with $300 billion reported by Benzinga on July 20, 2026, as higher yields attract income-seeking investors.
The outlook remains cautious due to bearish technical signals and Fed rate uncertainty. Opportunities exist from strong bond ETF demand, but risks include potential rate hikes and high-yield sector volatility. CNBC reported on June 18, 2026, elevated put volume against HYG, indicating bearish bets. Investors should weigh yield appeal against macroeconomic headwinds.
McKesson (MCK) trades at $828.84, down 1.49% on the day, with a bullish technical outlook supported by moving averages and key support at $826. The company shows strong revenue growth, reaching $359.05B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst sentiment is overwhelmingly positive with 24 buy ratings and a consensus price target of $932.83, indicating 12.5% upside potential.
The outlook for MCK remains favorable due to consistent earnings beats, robust cash flow generation, and leadership in healthcare distribution. Risks include thin profit margins (1.18% net margin) and high liabilities relative to equity. Investors should focus on execution in specialty pharma and oncology services as key growth drivers amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares iBoxx $ High Yield Corporate Bond ETF
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
